AspenBio Pharma, Inc. Stock Nasdaq
Equities
US0453462022
Blockchain & Cryptocurrency
End-of-day quote
Other stock markets
|
||
- USD | - |
Apr. 25 | Top Cryptocurrencies Mixed; Bitcoin Hovers Above $64,000 | MT |
Apr. 24 | Top Cryptocurrencies Fall; Bitcoin Falls Near $64,000 | MT |
Financials (USD)
Sales 2024 * | 492M | Sales 2025 * | 859M | Capitalization | 3.07B |
---|---|---|---|---|---|
Net income 2024 * | -126M | Net income 2025 * | 222M | EV / Sales 2024 * | 3.49 x |
Net cash position 2024 * | 1.35B | Net cash position 2025 * | 1.9B | EV / Sales 2025 * | 1.36 x |
P/E ratio 2024 * |
-22.8
x | P/E ratio 2025 * |
19
x | Employees | - |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 91.76% |
Managers | Title | Age | Since |
---|---|---|---|
Jason Les
CEO | Chief Executive Officer | 38 | 17-11-02 |
Colin Yee
DFI | Director of Finance/CFO | 48 | 22-03-31 |
David Schatz
COO | Chief Operating Officer | - | - |
Members of the board | Title | Age | Since |
---|---|---|---|
Hubert Marleau
BRD | Director/Board Member | 80 | 20-11-16 |
Lance D'Ambrosio
BRD | Director/Board Member | 66 | 21-05-23 |
Benjamin Yi
CHM | Chairman | 42 | 18-10-21 |
1st Jan change | Capi. | |
---|---|---|
-19.07% | 5.11B | |
+77.15% | 4.46B | |
-2.23% | 3.69B | |
+7.26% | 1.35B | |
-33.58% | 801M | |
+3.75% | 762M | |
-34.48% | 769M | |
-28.83% | 732M | |
-72.32% | 484M |